Search Results for 'sirolimus'
-
MedAlliance Enrolls First Patient in Sirolimus DEB vs. DES Study
Trial is the largest DEB study ever initiated, with more than 3,300 patients to be enrolled at approximately 50 sites in 15 countries.PR Newswire 12.02.21
-
Cardiovascular
Concept Medical Enrolls First Patient in Trial for Sirolimus-Coated Coronary Balloon
The study will compare angiographic outcomes of the MagicTouch sirolimus-coated balloon with SeQuent Please NEO.PR Newswire 10.15.20
-
Cardiovascular
Concept Medical Granted CE Certification for its Sirolimus Coated MagicTouch Group of Products
Company is now focused on marketing the products in Europe.Businesswire 11.25.19
-
Concept Medical Granted FDA Breakthrough Device Designation for Sirolimus Coated Balloon
The MagicTouch AVF Sirolimus Coated Balloon Catheter is indicated for use in percutaneous transluminal angioplasty.Newswire.com 10.14.19
-
Orchestra Biomed Appoints Chief Medical Officer
Executive has nearly 30 years of clinical and regulatory experience advancing medical devices in the cardiology and endovascular space.Globe Newswire 10.10.19
-
Cardiovascular | Surgical
Orchestra Biomed's Sirolimus-Eluting Balloon Wins Breakthrough Status
The Virtue SEB was awarded Breakthrough Device Designation for the treatment of below-the-knee peripheral artery disease.GlobeNewswire 09.17.19
-
Cardiovascular | Surgical
Concept Medical's Magic Touch AVF Sirolimus Coated Balloon Granted Breakthrough Status
Magic Touch AVF treats stenotic lesions of arteriovenous fistulae or arteriovenous graft in hemodialysis treatment of renal failure.PR Newswire 08.30.19
-
Cardiovascular
Orchestra BioMed Partners With Terumo Corporation on Development of Virtue Sirolimus-Eluting Balloon
Virtue SEB is expected to become a flagship therapeutic product for Terumo and will strengthen its U.S. and global portfolio of interventional solutions.Globe Newswire 08.01.19
-
Cardiovascular
BIOTRONIK's Orsiro Demonstrates Unique Benefits in Small Vessels
A subgroup analysis of the BIO-RESORT RCT three-year data showed significant differences in efficacy in favor of Ultrathin Strut Orsiro.PR Newswire 05.22.19
-
Cardiovascular | Surgical
Orchestra BioMed's Virtue Sirolimus-Eluting Balloon Wins Breakthrough Status
First and only non-coated sirolimus-eluting angioplasty balloon system to show promising clinical results.GlobeNewswire 04.25.19
-
Cardiovascular
Free Flow: A Look at the Current State of Stents
New designs and advancements in polymer technology are driving growth in the global coronary stent market.Michael Barbella, Managing Editor 03.07.19
-
Orchestra BioMed Appoints Chief Financial Officer
Industry veteran brings over 25 years of financial and operational management experience to the position.Globe Newswire 01.21.19
-
Orchestra BioMed Appoints Vice President of Strategy and Marketing
New hire brings extensive track record in marketing, strategy and commercial program development.Globe Newswire 11.12.18
-
Cardiovascular
-
Cardiovascular
Svelte Medical Systems Announces First Patient Enrolled in Pivotal OPTIMIZE Study
Trial is evaluating the world’s first drug-eluting stent-on-a-wire and a rapid exchange drug-eluting stent system.Business Wire 02.08.18
-
R&D & Design
Svelte Medical Systems Announces CE Mark Certification of DIRECT RX
Product combines bioresorbable drug coating, highly conformable stent design and proprietary balloon technology.Business Wire 11.02.16
-
Cardiovascular
Akesys Medical and Elixir Medical Announce First Human Implant of the PRAVA Bioresorbable Scaffold
Product is designed to maintain the large artery in the thigh open and restore blood flow to the leg.Business Wire 11.01.16
-
STENTYS Announces CE Marking of Its Longest Xposition Stent
Company expands portfolio with the addition of a 37 mm stent designed for long coronary lesions.Business Wire 06.08.16
-
Svelte Medical Systems Announces European Launch of Slender IDS
Product downsizes catheters, facilitates transradial intervention (TRI) and maximizes procedural efficiency.Videos Svelte Medical Systems Inc.
-
Cardiovascular
Svelte Medical Systems Gets CE Mark for Sirolimus-Eluting Stent
Company to begin U.S. IDE study next year.Svelte Medical Systems 12.15.15
